HP

 
IBV study: In the interest of the patient

While the pharmaceutical industry is seeking to replace the blockbuster model of drug development, healthcare is struggling with rapidly rising costs. This paper explores how by collaborating and sharing data, the two industries can realize the full value of the information they collect-and improve patient treatments.

Please fill out the form below in order to download the whitepaper

IBV study: In the interest of the patient
Required fields noted with *
  First Name*:
  Last Name*:
  Company / Organization Name*:
  Street Address:
  City:
  State/Province:
  Zip/Postal Code:
  Country:
  Email Address*:
 
 
E-mail: Stay informed about IBM products, services, and other offerings! If you want to stay informed by e-mail, please let us know by checking the box below.
 
Other communications: IBM or an affiliate or selected organizations may keep you informed about IBM related products, services and other offerings through ways other than e-mail, for example, by telephone or postal mail. If you do not want us to use the information you provided here to keep you informed through other ways, please indicate in the box below.